Relationship between cognitive dysfunction, gait, and motor impairment in children and adolescents with neurofibromatosis type 1

Developmental Medicine and Child Neurology

Volumn 56, Issue 5, 2014, Pages 468-474

  Champion, Joel A ^a   Rose, Kristy J ^b   Payne, Jonathan M ^a,b   Burns, Joshua ^a,b,c   North, Kathryn N ^a,b,d  

^a University of Sydney   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGILITY; ARTICLE; BALANCE IMPAIRMENT; CHILD; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; EXECUTIVE FUNCTION; FEMALE; GAIT; HUMAN; MALE; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEUROFIBROMATOSIS; PRIORITY JOURNAL; RUNNING; SPATIAL MEMORY; VELOCITY; WORKING MEMORY;

ADOLESCENT; AGE FACTORS; CHILD; COGNITION DISORDERS; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; MOVEMENT DISORDERS; NEUROFIBROMATOSIS 1; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REFERENCE VALUES;

EID: 84898448300     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12361     Document Type: Article

References (45)

1. Evans DG, Howard E, Giblin C, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 2010; 152A: 327-32.
2. Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics 2009; 123: 124-33.
3. Lehtonen A, Howie E, Trump D, Huson SM. Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence. Dev Med Child Neurol 2012; 55: 111-25.
4. Hyman SL, Shores EA, North KN. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 2005; 65: 1037-44.
5. Hyman SL, Shores EA, North KN. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Dev Med Child Neurol 2006; 48: 973-7.
6. Johnson BA, MacWilliams BA, Carey JC, Viskochil DH, D'Astous JL, Stevenson DA. Motor proficiency in children with neurofibromatosis type 1. Pediatr Phys Ther 2010; 22: 344-8.
7. Soucy EA, Gao F, Gutmann DH, Dunn C. Developmental delays in children with neurofibromatosis type 1. J Child Neurol 2012; 27: 641-4.
8. North K, Joy P, Yuille D, Cocks N, Hutchins P. Cognitive function and academic performance in children with neurofibromatosis type 1. Dev Med Child Neurol 1995; 37: 427-36.
9. Skinner RA, Piek JP. Psychosocial implications of poor motor coordination in children and adolescents. Hum Mov Sci 2001; 20: 73-94.
10. Kanioglou A, Tsorbatzoudis H, Barkoukis V. Socialization and behavioral problems of elementary school pupils with developmental coordination disorder. Percept Motor Skills 2005; 101: 163-73.
11. Roebers CM, Kauer M. Motor and cognitive control in a normative sample. Dev Sci 2009; 12: 175-81.
12. Michel E, Roethlisberger M, Neuenschwander R, Roebers CM. Development of cognitive skills in children with motor coordination impairments at 12-month follow-up. Child Neuropsychol 2011; 17: 151-72.
13. Alloway TP, Temple KJ. A comparison of working memory skills and learning in children with Developmental Coordination Disorder and moderate learning difficulties. Appl Cognitive Psych 2007; 21: 473-87.
14. Alloway TP. Working memory, reading, and mathematical skills in children with developmental coordination disorder. J Exp Child Psychol 2007; 96: 20-36.
15. Diamond A. Close interrelation of motor development and cognitive development and of the cerebellum and prefrontal cortex. Child Dev 2000; 71: 44-56.
16. Buderath P, Gärtner K, Frings M, et al. Postural and gait performance in children with attention deficit/hyperactivity disorder. Gait Posture 2009; 29: 249-54.
17. Leitner Y, Barak R, Giladi N, et al. Gait in attention deficit hyperactivity disorder. J Neurol 2007; 254: 1330-8.
18. Giedd JN, Blumenthal J, Molloy E, Castellanos FX. Brain imaging of attention deficit/hyperactivity disorder. Ann N Y Acad Sci 2001; 931: 33-49.
19. Timmann D, Diener HC. Coordination and ataxia. In: Goetz CG, Pappert EJ, editors. Textbook of Clinical Neurology. Orlando: Sanders, 2003: 299-315.
20. Hausdorff JM, Cudkowicz ME, Firtion R, Wei JY, Goldberger AL. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease. Mov Disord 1998; 13: 428-37.
21. Neurofibromatosis Conference Statement. Arch Neurol 1988; 45: 575-8.
22. Payne JM, Hyman SL, Shores EA, North KN. Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior. Child Neuropsychol 2011; 17: 313-29.
23. Bruininks RH, Bruininks BD. Bruininks-Oseretsky Test of Motor Proficiency. 2nd edn. Minneapolis: NCS Pearson, 2005.
24. Wuang YP, Su CY. Reliability and responsiveness of the Bruininks-Oseretsky Test of Motor Proficiency-Second Edition in children with intellectual disability. Res Dev Disabil 2009; 30: 847-55.
25. Burns J, Ryan MM, Ouvrier RA. Evolution of foot and ankle manifestations in children with CMT1A. Muscle Nerve 2009; 39: 158-66.
26. Thorpe DE, Dusing SC, Moore CG. Repeatability of temporospatial gait measures in children using the GAITRite electronic walkway. Arch Phys Med Rehabil 2005; 86: 2342-6.
27. Dusing SC, Thorpe DE. A normative sample of temporal and spatial gait parameters in children using the GAITRite electronic walkway. Gait Posture 2007; 25: 135-9.
28. Bilney B, Morris M, Webster K. Concurrent related validity of the GAITRite walkway system for quantification of the spatial and temporal parameters of gait. Gait Posture 2003; 17: 68-74.
29. Owen AM, Downes JJ, Sahakian BJ, Polkey CE, Robbins TW. Planning and spatial working memory following frontal lesions in man. Neuropsychologia 1990; 28: 1021-34.
30. Payne JM, Arnold SS, Pride NA, North KN. Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1? Dev Med Child Neurol 2012; 34: 898-904.
31. Owen AM, Morris RG, Sahakian BJ, Polkey CE, Robbins TW. Double dissociations of memory and executive functions in working memory tasks following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Brain 1996; 119: 1597-615.
32. Robbins TW. Dissociating executive functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 1996; 351: 1463-70.
33. Gioia G, Isquith P, Guy S, Kenworthy L. Behavior Rating Inventory of Executive Function-Professional Manual. Odessa, FL: Psychological Assessment Resources, 2005.
34. Shuster J, Toplak ME. Executive and motivational inhibition: associations with self-report measures related to inhibition. Conscious Cogn 2009; 18: 471-80.
35. Gilotty L, Kenworthy L, Sirian L, Black DO, Wagner AE. Adaptive skills and executive function in autism spectrum disorders. Child Neuropsychol 2002; 8: 241-8.
36. Lythgo N, Wilson C, Galea M. Basic gait and symmetry measures for primary school-aged children and young adults whilst walking barefoot and with shoes. Gait Posture 2009; 30: 502-6.
37. Lythgo N, Wilson C, Galea M. Basic gait and symmetry measures for primary school-aged children and young adults. II: walking at slow, free and fast speed. Gait Posture 2011; 33: 29-35.
38. Bladen M, Alderson L, Khair K, Liesner R, Green J, Main E. Can early subclinical gait changes in children with haemophilia be identified using the GAITRite walkway. Haemophilia 2007; 13: 542-7.
39. Rinehart NJ, Tonge BJ, Iansek R, et al. Gait function in newly diagnosed children with autism: cerebellar and basal ganglia related motor disorder. Dev Med Child Neurol 2006; 48: 819-24.
40. Benedetti MG, Piperno R, Simoncini L, Bonato P, Tonini A, Giannini S. Bait abnormalities in minimally impaired multiple sclerosis patients. Mult Scler 1999; 5: 363-8.
41. Kelly VE, Schrager MA, Price R, Ferrucci L, Shumway-Cook A. Age-associated effects of a concurrent cognitive task on gait speed and stability during narrow-base walking. J Gerontol A Biol Sci Med Sci 2008; 63: 1329-34.
42. Mochizuki H, Ugawa Y. Cerebellar ataxic gait. Brain Nerve 2010; 62: 1203-10.
43. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357-81.
44. Brown JA, Emnett RJ, White CR, et al. Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice. Hum Mol Genet 2010; 19: 4515-28.
45. Nelson AJ, Zwick D, Brody S, et al. The validity of the GaitRite and the Functional Ambulation Performance scoring system in the analysis of Parkinson gait. NeuroRehabilitation 2002; 17: 255-62.